digital how-natural-language-processing-can-make-difference-pharma 
pharmaphorum
OCTOBER 3, 2022
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses.
pharmaphorum
APRIL 30, 2021
Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. A long way to go” for digital health reimbursement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 16, 2020
Findacure’s Rick Thompson looks at how these technologies could bring us closer to treatments for underserved rare diseases. By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs. In the age of artificial intelligence, no trial data should be going to waste.
Cloudbyz
FEBRUARY 3, 2021
We can help businesses keep a strong command over their sales performance management infrastructures. With assurance of comprehensive skills, knowledge, capabilities and resources at our disposal, we can secure competitive advantages. How can virtual trial ease the process? Risk Based Monitoring (RBM). eCOA / ePRO.
Drug Discovery World
APRIL 20, 2023
Memory, language, planning and attentional differences have been found between those that have and have not experienced Covid-19 infection and tend to be related to the severity of ongoing illness. Even mild cognitive impairment can have significant societal and economic consequences. How this occurs is not yet understood.
Pharma Marketing Network
JUNE 10, 2020
RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member. So tell me about the latest happenings that you’re seeing in the world of healthcare and digital innovation.
Pharma Marketing Network
JUNE 8, 2020
Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I come to the pharma space from being a medical operator of clinics for the last 15 to 20 years where we took care of patients with specific disease conditions that were often overlooked. Bob and Mark thanks for joining us today. Mark (83Bar): Yea thank you.
Expert insights. Personalized for you.
116 
Let's personalize your content